Modifying factors of cerebral amyloid angiopathy and related intracerebral hemorrhage: cues to action

Abstract

This dissertation demonstrates that cerebral amyloid angiopathy (CAA) is a disease with a complex and heterogeneous course. Not only amyloid-β deposition plays a role, but also factors such as cerebellar involvement, blood pressure variability, and neuroinflammation are of significant importance. By identifying novel clinical, radiological, and biological markers, this work provides valuable tools for improving diagnosis, refining prognosis, and guiding the development of future therapeutic strategies.

The findings highlight that CAA cannot be understood as a uniform condition; instead, it presents with diverse manifestations and underlying mechanisms that may differ between patients. This underscores the need for a more personalized approach to both research and clinical care. The integration of multiple types of markers offers a more comprehensive understanding of disease progression and may help clinicians better predict outcomes.

Although effective prevention and treatment options are currently lacking, the insights gained from this research offer promising directions for future interventions. In particular, targeting modifiable factors such as blood pressure variability and neuroinflammatory processes may open new avenues for therapy. Ultimately, these advances provide hope that more precise and targeted interventions will be developed, potentially leading to improved disease management and better outcomes for patients with CAA.